
Myalink platform improves care for patients with myasthenia gravis
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000…
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000…
With the support of SPARK-BIH and the BIH Biomedical Innovation Academy (BIA), the first cohorts in the project and personal funding programs of the…
BIH researchers and colleagues showed that public large-language models, such as DeepSeek, perform as well as proprietary models (e.g. GPT4o) that…
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH)…
Researchers from the Berlin Institute of Health at Charité (BIH), the Center for Musculoskeletal Surgery at Charité – Universitätsmedizin Berlin, Jena…
Researchers from the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin have gained new insights into the…
A study under the leadership of Prof. Leif Erik Sander has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84%…
A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19,…
Dr. Maik Pietzner receives a W2 professorship for life for “Health Data Modeling” at the Berlin Institute of Health at Charité (BIH). His aim is to…